4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000006
Chief Medical Officer sold 2,845 shares at $44.78 ($127,399)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2022-01-05 | Sale | −2,845 | $44.78 | $127,399 | 163,285 | I: show line 1 in the form |
| Open-market sales · 2,845 sh · avg $44.78 · $127,399 | |||||||
Loading xslF345X03/wf-form4_164159673634515.xml…